F755 in Delaware. Pick another state for the same tag.
Against expectation — 2025
Delaware cites F755 less often than its own record predicts
Versus expected share0.54×
0.54 times the national share — cited less often here than elsewhere.
Share of Delaware citations1.28%
Of every deficiency written in Delaware in 2025, this is the portion that was F755.
Delaware1.28%
National2.35%
Share of all citations that were F755.
Each state is measured against its own expected share, not against other states.
In the surveyor’s words
What Delaware surveyors wrote
F755 findings written in Delaware, one from each severity band recorded here, most serious first.
Severity is as the surveyor wrote it. Some findings had already been corrected before the survey.
D · No harm, potential for more than minimal, isolatedMay 22, 2026
Based on record review and interview it was determined that for two (R77 and R2) out of six residents reviewed for unnecessary medications the facility failed to ensure prompt pharmacy services were provided to newly admitted residents resulting in missed doses of medications. Findings include:3/28/24 - The facility policy for admissions documented that persons will be accepted for admission on ly if the services and or care provided can reasonably be provided. 1. Review of R77s' clinical record revealed: 4/4/26 8:00 PM - R77 was admitted to the facility with multiple diagnoses including anxiety. 4/4/26 - A physician's order was written for R77 to receive clonazepam twice daily for anxiety. …
Deficiency Index is independent and is not affiliated with, endorsed by, or approved by CMS, Medicare, or any government agency. About this data · Report a correction